Hepatocyte growth factor (HGF) and its receptor, Met, are key determinants of distinct developmental processes. Although HGF is cardio-protective in a number of cardiac pathologies, it remains unknown whether HGF/Met signaling is essential for myocardial development or normal physiological function in adults. We investigated the requirement of HGF/Met signaling in cardiomyocyte for heart development and heart function in adult mice. We inactivated Met receptor in cardiomyocytes by conditional deletion of the floxed c-met exon 16 using the Cre-α−MHC mouse line (termed α−MHCMet). Although α−MHCMet mice showed normal heart development and were viable and fertile, by 6 months of age males developed cardiomyocyte hypertrophy, associated with interstitial fibrosis. A significant upregulation in the markers of myocardial damage β-MHC, ANF, and connexin-43 was also observed. By the age of 9 months, α−MHCMet mutant males displayed systolic cardiac dysfunction. Mechanistically, we provide evidence of a severe imbalance in the antioxidant defenses in α−MHCMet hearts involving a reduced expression and activity of catalase and superoxide dismutase, with consequent reactive oxygen species accumulation. Similar anomalies were observed in females, although with a slower kinetics. We also show that Met signaling downregulation leads to an increase in TGF-β production and a decrease in p38MAPK activation, which may contribute to phenotypic alterations displayed in α−MHCMet mice. In fact, HGF acting through p38α upregulated antioxidant enzymes in cardiomyocytes. Our results highlight that HGF/Met signaling in cardiomyocytes plays a physiological cardio-protective role in adult mice by acting as an endogenous regulator of heart function through the control of oxidative stress.
Introduction
The hepatocyte growth factor (HGF) receptor, Met, is a tyrosine kinase receptor expressed in a wide variety of cell types. It regulates several cellular functions, including proliferation, scattering, differentiation and "invasive growth", either during development or under some pathological conditions [1] [2] [3] [4] . Upon HGF binding, Met is autophosphorylated in different tyrosine residues, leading to the recruitment of several SH2-domain containing proteins through the multifunctional docking site located in its carboxy-terminal tail [5] . Both HGF and Met are essential during development as shown by the embryonic lethality of met or hgf mutant mice that display defects in placenta, liver, and muscle [6] [7] [8] [9] [10] [11] . This embryonic lethality imposes the use of conditional inactivation strategies to explore its functional requirement during embryogenesis or after birth.
HGF protects rats from myocardial infarction [12] and/or ischemia/reperfusion injury [13] .
Post-infarction treatment with HGF improves left ventricular remodeling and heart function in mice [14] . In addition, HGF also improved heart functionality and promoted proliferation of myocardial progenitor cells in doxorubicin-induced cardiomyopathy [15] . Moreover, in a hamster model of cardiomyopathy, treatment with HGF prevented heart fibrosis, remodeling, and dysfunction [16] .
Together, these findings indicate that HGF/Met axis exerts a cardio-protective role under pathological conditions. On the other side, some in vitro data showed that HGF induced the expression of cardiac markers in mesenchymal stem cells [17] and increased cardiac differentiation of embryonic stem cells [18] . Both HGF and Met are expressed in cardiac myocytes during early cardiogenesis [19, 20] . Recent data indicated that neonatal cardiomyocytes express Met and respond to HGF by increasing proliferation in a mouse model of HGF supra-physiological overexpression [21] . Although these results suggest that enhanced HGF/Met signaling impacts heart development, it remains unknown whether endogenous activity levels of HGF/Met is required for heart development and/or physiology after birth.
In this study, we evaluated genetically the role played by the HGF/Met axis in the developing and adult heart using a conditional knock-out mouse model lacking Met signaling in cardiomyocytes.
This was accomplished by the conditional deletion of c-met exon 16 from c-met flox/flox mice [22] by employing a transgenic line expressing the Cre recombinase under the control of the α-myosin heavy chain (α-MHC) promoter [23] . Exon 16 encodes a residue in the Met kinase domain that is critical for the binding of ATP and therefore for the tyrosine kinase activity of the receptor. On the other hand, the α-MHC promoter is active in mouse embryos throughout the myocardium starting from E8 [24] .
Previous reports have shown that by E12.5, α-MHC is highly expressed in atria and to a lesser extent in the ventricles, whereas its expression increases in the ventricles after birth [25] . Therefore, the α-MHC-Cre line allows c-met inactivation in cardiomyocytes at early heart developmental stages.
Using the conditional α−MHCMet mouse model, we found that while Met signaling in cardiomyocytes appears to be dispensable for heart development, it is required to protect cardiomyocytes from oxidative stress, thus preventing cardiomyocyte hypertrophy, heart fibrosis, and heart dysfunction in adult mice. Together, these studies unveil that HGF/Met signaling in cardiomyocytes is a key regulator for proper heart function.
Materials and methods

Generation of cardiomyocyte c-met knock-out mice and genotyping
The animals used in our research program were handled in compliance with the institutional and European Union guidelines for animal care and welfare. All mouse lines were maintained and bred at the UCM facility, allowed food and water ad libitum and routinely screened for pathogens in accordance with FELASA (Federation of European Laboratory Animal Science Associations)
procedures.
c-met flox/flox (wt) mouse line (in a CD1 genetic background), which carries c-met alleles with exon 16 flanked by loxP sites was obtained from Dr. S. Thorgeirsson [22] . This mouse was crossed with α-MHC-Cre transgenic mouse in CD1 background (obtained from Dr. M. D. Schneider [23] ) to generate α-MHC-Cre/+: c-met flox/+ mice, which were then crossed with c-met flox/flox mice. Cremediated excision led to a null allele for c-met, which encodes an inactive Met receptor only in cardiomyocytes. Mice genotyping was performed by PCR analysis (supplemental detailed methods).
RT-qPCR analysis
After the isolation of total RNA, DNA and proteins using AllPrep DNA/RNA/Protein Mini Kit, RNA was reverse transcribed using SuperScript III RT kit (Quiagen, 18080) to generate cDNA. Then, Real Time PCR was performed using specific primers (see supplemental methods). Quantification was performed calculating RQ (2 -ΔΔCt ), so referring the values to control mice (supplemental methods). An
Invitrogen custom RNA profiling by RT-qPCR was performed for the analysis of anti-and pro-fibrotic genes and those involved in reactive oxygen species (ROS) metabolism (supplemental methods).
Western-blot analysis
Western-blot analysis was carried out as previously described [26] . Proteins were separated by electrophoresis using Anderson or SDS-page gels, and transferred to nitrocellulose membranes that were probed with the following antibodies: catalase (Sigma, C0979), superoxide dismutase-2 (SOD-2) (Upstate Biotech, 06-984), β-actin (Sigma A5441), c-Met (Santa Cruz Biotechnology sc-260), cytochrome c (BD 556433), porin (Sigma V2139), phospho-p38MAPK (Cell Signaling, 9211), p38α
(Santa Cruz Biotechnology sc-535).
Histology
Hearts were processed for histology using conventional techniques involving paraformaldehyde fixation and paraffin embedding. The degree of interstitial fibrosis was assessed by image analysis on Mallory's trichrome stained tissue sections (see supplemental methods). Laminin immunostaining of heart sections was done to delineate the cardiomyocyte profiles, measuring their areas with the ImageJ analysis package. Apoptotic cardiomyocytes were detected by using anti-desmin (Sigma, D1033) and anti-active caspase-3 antibodies (Promega, G74819).
ROS detection and quantification
Reactive oxygen species (ROS) accumulation in hearts was detected by staining of frozen sections with hydroxyethidine or by immunolocalization of 4-OH-Nonenal (Alpha Diagnostics, HNE11-S) in paraffin sections. Stained areas were assessed on digitalized images using ImageJ software.
Carbonylated proteins were quantified as an indirect measurement of ROS [27] . Heart extracts were treated with 2,4-Dinitrophenylhydrazine or maintained untreated (blank). Then, proteins were precipitated with TCA and absorbance at 360 nm was determined. The concentration of carbonylated proteins was calculated upon correction with the blanks and referred to protein content (supplemental methods).
Measurement of catalase, SOD, and cytochrome c oxidase activities
Catalase activity was measured by quantification of peroxide decomposition spectrophotometrically at 240 nm. Superoxide dismutase (SOD) activity was quantified using a Kit (BioVision) (supplemental methods). Cytochrome c oxidase activity was determined by quantification of cytochrome c oxidation spectrophotometrically at 550nm.
Electrocardiographic measurements in conscious mice using radiotelemetry
Telemetric electrocardiogram (ECG) recordings in conscious mice were carried out using an implantable telemetry system with ECG transmitters (ETA-F10) (Data Sciences International, St Paul, MN, USA). Recordings were taken every 3 h, 5 min/each, over a 24 h period and analyzed using ECG-auto software supplied by Data Systems (supplemental methods).
Echocardiographic assessment of cardiac function and structure
Transthoracic echocardiography was performed on lightly anesthetized mice using a Vivid 7
(GE Medical Systems) cardiac ultrasound machine equipped with a 10-14-MHz transducer il3L (GE Medical Systems), as previously described [28] . Measurements of chamber dimensions and cardiac function were made offline (EchoPac Software, GE Medical Systems). Structural and functional heart parameters were calculated as previously described [28] (supplemental methods).
Assays in cardiomyocytes derived cell lines
Cardiomyocyte cell lines (wt and p38α-/-) were generated from E9.5 immortomouse embryos expressing a temperature-sensitive large T antigen (LTAg) [29] . Before the experiments, cells were transferred to 37°C in the absence of IFN-γ to abolish LTAg expression. Neonatal cardiomyocyte cell lines were obtained by immortalization of neonatal mice (P4) cardiomyocytes by transfection with LTAg. For the experiments, all the cell lines were maintained in a low serum medium (2%) and treated with the Met inhibitor SU11274 (5µM) or TGF-β (1ng/mL) in the presence or absence of HGF (30ng/mL, 16h pretreatment) or N-acetyl cysteine (2.5mM) for 1-4 days as indicated. fig. 1 ). So, both were indistinctly used as controls.
Results
Conditional inactivation of Met in cardiomyocytes does
Efficiency of the c-met deletion was determined by PCR and Western-blot analysis. Exon 16 was deleted at E15.5 as detected by the presence of the deletion-specific band. Consistently, westernblot analysis showed a sharp decrease in c-Met protein levels in E15.5 α−MHCMet mutant embryos (Fig. 1a) , confirming the efficient deletion of Met, as shown in other Cre lines [22, 31] . Quantification revealed a c-Met deletion of 60%-80% and 80-95% in embryonic (E15.5) and adult α−MHCMet hearts, respectively (data not shown). Probably, most of this remaining c-Met expression occurs in non-cardiomyocyte cells. No significant differences were found between controls and α−MHC-Met mutants either during development or after birth ( Fig. 1b and c) . These data indicate that c-Met signaling in cardiomyocytes is dispensable for heart development.
Conditional α−MHCMet mutants were born following a mendelian ratio, have a normal lifespan and weight curve (not shown), thus indicating that other tissues has been preserved from Met inactivation. Therefore, the α−MHCMet mutant mice represent a unique genetic setting to investigate Met signaling requirement for heart function. This issue was assessed by performing a series of morphological, molecular, and functional studies on 3, 6, and 9 months old α−MHCMet mice. It is well know that the gender may influence the molecular process underlying heart function, as shown by a number of studies in mice [32] [33] [34] . We therefore first focused our analysis on α−MHCMet males.
Whereas morphological analysis of the heart did not reveal significant abnormalities in 3 months old α−MHCMet males, we observed structural abnormalities in 6 months old α−MHCMet mutant hearts (Fig. 2a, b, d ). In particular, a significant increase in the cross-sectional area of cardiomyocytes was observed in α−MHCMet mutant hearts from 6 and 9 months old males compared to controls (Fig. 2b, c and supplementary fig. 2a ). In addition, myocardial fibrosis, extensive areas with cardiomyocyte disorganization and strong collagen deposition were also found in the heart of 6 and 9 months old α−MHCMet males compared to controls (Fig. 2d, e and supplementary fig. 2b ). As fibrosis can be a physiological response to cardiomyocyte death, we analyzed the presence of active caspase-3 in cells and found increased levels in the fibrotic areas of hearts from α−MHCMet mutant males compared to controls (Fig. 2f) .
We next asked whether morphological defects observed in α−MHCMet males were parallel to heart dysfunction markers. In particular, we performed RT-qPCR studies to assess the levels of β-MHC and atrial natriuretic factor (ANF), known to be induced during hypertrophy, and of connexin 43 (Cx43), which becomes up-regulated in compensated hypertrophy [35, 36] . No differences were observed in 3 months old mutants (Fig. 2g) . In contrast, we found increased mRNAs expression levels of Cx43, ANF, and β-MHC in the heart of 6 months old α−MHCMet males compared to controls (Fig.   2g ). Moreover, RT-qPCR analysis of the expression of pro-fibrotic genes such as TGF-β2 and TGF-β3, or fibrotic markers such as α-smooth muscle actin (Acta-2) revealed significantly increased levels in α−MHCMet males compared to controls (Fig. 2h) .
We next assessed whether these morphological and molecular alterations impacted the heart electrical function by performing electrocardiography (ECG) analyses. Whereas ECG was normal in 3 months old α−MHCMet mice (data not shown), we found specific alterations in 6 months old α−MHCMet males. Anomalies consisted in the reduction or disappearance of the J wave [37] and a deepening of the S-P interval, usually reaching -0.2 mV (Fig. 3a) . However, data from echocardiographic analysis demonstrated no significant differences in cardiac output or left ventricular mass in α−MHCMet males (not shown). In contrast, echocardiographic analyses of 9 months old α−MHCMet males revealed signs of systolic dysfunction characterized by a significantly higher left ventricular systolic diameter and volume compared to controls. Shortening fraction and ejection fraction were also significantly decreased ( Fig. 3b and c) .
Morphological, molecular, and functional studies were also performed in females. Increased cardiomyocyte size and extensive areas of fibrosis were detected in 9 months old females (Supplementary fig. 3a -c). Echocardiographic analysis revealed no significant differences between α−MHCMet and controls, although a similar tendency as that found in mutant males was observed (data not shown). Together, these studies showed that HGF/Met signaling in cardiomyocytes is dispensable during development and in young mice, whereas it is required for proper heart function in adult mice. Moreover, they indicate that males are more susceptible to altered HGF/Met signaling than females.
Loss-of-function of Met signaling disrupts the antioxidant defenses in cardiomyocytes, leading to an increase in ROS accumulation and altered mitochondria in adult mice heart
The oxidative stress increases during aging, leading to cardiac alterations, including hypertrophy and heart dysfunction [38] . As HGF/Met signaling regulates the antioxidant defenses in different cells types by preventing ROS accumulation [39-41], we investigated whether heart defects observed in adult α−MHCMet males were linked to an imbalance in pro-and anti-oxidant mechanisms. We found that expression levels of antioxidant enzymes such as catalase and SOD-2
were decreased in the heart of 6 months old α−MHCMet males compared to controls (Fig. 4a ).
Consistently, catalase and SOD-2 activities were also decreased in α−MHCMet males (Fig. 4b ). We also found that reactive oxygen species were accumulated in cardiomyocytes of α−MHCMet males as shown by 2-hydroethidine staining and 4-OH-nonenal immunolocalization in tissue sections from 6 and 9 months old mice, respectively ( Fig. 4c and d ). In addition, carbonylated protein levels increased in 6 months old mutant males ( Fig.4e) , as a readout of proteins oxidation by ROS.
Because ROS accumulation can be either a consequence of an altered mitochondrial function and/or can lead to mitochondrial damage, we next investigated whether α−MHCMet 6 months old male hearts presented alterations in mitochondria. We found that the mitochondrial proteins porin and cytochrome c were significantly decreased in mutants as compared to controls (Fig. 4f) . Consistently, cytochrome c oxidase activity was significantly reduced in α−MHCMet mutant hearts (Fig. 4g ). In contrast, we did not observe any alteration in anti-oxidant enzymes, ROS accumulation, carbonylated proteins or mitochondrial proteins in 6 months old α−MHCMet females, consistent with normal morphology and function, as previously assessed (Supplementary fig.3 ). However, in 9 months old mutant female hearts antioxidant enzymes levels significantly decreased and ROS accumulation was detected (Supplementary fig. 4c ), accordingly with the detection of fibrosis and the increased cardiomyocytes size (Supplementary fig. 3 ) Altogether, these findings strongly indicate that HGF/Met signalling is required for normal mitochondrial function and redox homeostasis in adult cardiomyocytes.
Met acts on p38 MAPK to increase antioxidant enzymes levels and counteracts TGF-β effect in cardiomyocytes
We next aimed at uncovering the molecular mechanism by which HGF/Met signaling in cardiomyocytes ensures proper levels of antioxidant enzymes. As it has been shown that p38α MAPK regulates the expression of SOD-2 and catalase in mouse embryonic fibroblast (MEFs) [42], we assessed p38α MAPK signaling in control and α−MHCMet mutant hearts. Notably, we found that p38α MAPK phosphorylation levels were significantly decreased in α−MHCMet hearts from 6 and 9 months old mice ( Fig. 5a and Supplementary fig. 4g ). We therefore studied whether p38α was required for HGF/Met-mediated regulation of antioxidant enzymes in cardiomyocytes through applying pharmacological approaches on embryonic cardiomyocyte cell lines generated from wildtype or p38α deficient mice (p38α-/-). We found decreased levels of catalase and SOD-2 proteins in p38α-/-cardiomyocytes compared to controls ( Fig. 5b and c). Met inhibition with SU11274 treatment reduced the levels of catalase, SOD-2, and phospho-p38α MAPK in wild-type cells, but not in p38α-/-mutant cells ( Fig. 5b and c). These findings were further confirmed using neonatal cardiomyocytes (data not shown). HGF stimulation increased the levels of catalase and SOD-2 proteins in wt, but not in p38α -/-cardiomyocytes ( Fig. 5c ). Thus, HGF/Met acts through p38 MAPK to increase catalase and SOD-2 levels.
The increased levels of TGF-β isoforms observed in α−MHCMet mutant hearts ( Fig. 2h) prompted us to investigate whether the levels of antioxidant enzymes were influenced by TGF-β.
Notably, we found that TGF-β led to a decrease in catalase and SOD-2 protein levels in both wild-type and p38α -/-cardiomyocytes ( Fig. 5d ). In contrast, TGF-β treatment did not modify phospho-p38α levels significantly (Fig. 5d ). Moreover, HGF prevented the decrease in catalase and SOD-2 protein levels mediated by TGF-β, only in wt cardiomyocytes (Fig. 5e ).
Taken together, these findings indicate that HGF/Met acts through p38 MAPK to increase the levels of antioxidant enzymes in cardiomyocytes, possibly by counteracting the effects elicited by TGF-β.
Increased cardiomyocyte size occurring in the absence of Met signaling is prevented by antioxidant treatment
As alteration of Met signaling in cardiomyocytes leads to decreased antioxidant enzymes levels, it is tempting to speculate that accumulation of ROS in α−MHCMet mutant hearts could be responsible for the increased size of cardiomyocytes. This would be coherent with previous studies
showing that ROS accumulation is responsible for cardiomyocyte hypertrophy as happens in Sirt3-deficient mice [43] . We therefore tested this hypothesis using wild-type neonatal cardiomyocyte cell lines. We found that Met inhibition led to increased cell size in a time-dependent manner (Fig. 6a) .
Treatment of cardiomyocytes with the antioxidant N-acetyl-cysteine prevented the increased size of cells exposed to Met inhibitors (Fig. 6b ). These findings support that ROS accumulation might account for the cardiomyocyte hypertrophy occurring in the absence of HGF/Met signaling.
Discussion
Genetically modified mouse models have unveiled several genes involved in heart development and in regulation of adult heart physiology. However, key players for adult heart function and homeostasis remain to be uncovered. Their identification would allow the discovery of key mechanisms that will be helpful for a better understanding of heart dysfunction, for its use in diagnosis and for regenerative interventions. HGF/Met is an attractive signal as administration of exogenous HGF has a cardio-protective role in models of heart damage [12] [13] [14] . By exploring in vivo the role played by Met in heart during embryogenesis and in adulthood through selective inactivation of the met gene in cardiomyocytes, we demonstrated that whereas it is not essential for heart development, Met is required for heart homeostasis in adult mice. Intriguingly, Met becomes progressively required during aging. Thus, whereas 3 months old α−MHCMet mutant hearts are normal, hearts from 6 months old males show an increase in cardiomyocyte size and myocardial fibrosis. Molecular markers of cardiac damage such as ANF, β-MHC, or Cx43 were up-regulated in α−MHCMet males. This was accompanied by abnormal ECG (S-P segment depression), a feature reported in rats with isoproterenol-induced cardiac hypertrophy [44] . As age increases, lack of HGF/Met signaling impacts heart function, and 9 months old α−MHCMet males suffer systolic left ventricle dysfunction. We found that Met regulates antioxidant enzymes and mitochondrial content and/or activity. Hence, heart anomalies are associated with down-regulation of antioxidant enzymes, leading to increased oxidative stress. We highlighted a significant reduction in protein levels and enzymatic activities of catalase and SOD-2 in the heart of α-MHCMet mutants, paralleled by ROS accumulation, first in males and later in females. The delayed dysfunction observed in α−MHCMet females is most likely due to the existence of estrogen-induced cardio-protective mechanisms, which have been extensively studied [32] [33] [34] and which might partially compensate HGF/Met requirement for heart function in young females. signaling not only would be cardioprotective, but it would be also critically involved in cardiac homeostasis.
The herein described property of HGF/Met signaling to protect cardiomyocytes from ROSinduced damage agrees with previous studies performed under non-physiological conditions. For example, HGF protects cultured adult rat cardiomyocytes from apoptosis induced by oxidative stress upon serum deprivation, treatment with daunorubicin, or hydrogen peroxide [49] . A role for HGF preventing heart fibrosis has been previously described in the cardiomyopathic Syrian hamster [16] . In this pathological model, HGF down-regulation in endothelial and interstitial cells triggered TGF-β1 up-regulation and interstitial fibrosis, whereas HGF treatment decreased TGF-β1 expression and suppressed fibrosis. We herein show that in adult heart under physiological conditions, HGF/Met signaling in cardiomyocytes is also essential to prevent fibrosis. Furthermore, we demonstrate a negative correlation between Met activity and levels of the pro-fibrotic factors such as TGF-β2 and TGF-β3. We also provide evidence that TGF-β treatment leads to down-regulation of antioxidant enzymes in cultured cardiomyocytes, thus linking fibrosis and oxidative stress. In summary, our studies evidence the cell autonomous requirement of HGF/Met signaling in cardiomyocytes to ensure heart function in adult mice by preventing oxidative stress-induced damage.
Our findings open a new perspective to further explore HGF/Met as putative diagnostic markers of individuals subjective to heart defects and as therapeutic intervention to treat cases of idiopathic cardiomyopathies. Age (months) 9 9
Body weight (g) 53.73 ± 4.67 60.0 ± 6.11
Heart rate (bpm) 
RT-qPCR analysis
After the isolation of total RNA, DNA and proteins using AllPrep DNA/RNA/Protein Mini Kit (Quiagen, 80004), 1-3 µg of RNA was reverse transcribed using SuperScript III RT kit (Quiagen, 18080) to generate cDNA. Then, quantitative PCR analysis was performed by Real Time PCR using SYBR Green (Roche) and the following specific primers. For ANF: forward: 5´TCCTAGCCAGTCTCCAGAGC3´ and reverse: 5´TTTGGGTGTTCTTTTGTGAGG3´; β-MHC:
forward: 5´GGACCTTGGAAGACCAGATG3´ and reverse: 5´CGGGTTAGCTGAGAGATCAGAG3´; Connexin 43: forward: 5´AGT CCTTCCCCATCTCTCAC3´ and reverse: 5´GCTTCTCTTCCTTTCTCATCAC3´; TGF-β2: forward: 5´GCCGAGCAGCGGATTGAACTGTA3´ and reverse: 5´AGCCATTCACCCTCCGCTCT3´, TGF-β3: forward: 5´CGGGAGTTGCTGGAAGAGATGC 3´ and reverse: 5´TCATTGTGCTCCGCCAGTCCCT 3´; Acta 2 (α-Smooth muscle actin) forward: 5´AGAGTGGAGAAGCCCAGCCAGT 3´and reverse: 5´AGAGCCCAGAGCCATTGTCGCA3´. The amplified bands were normalized using as an internal control, GAPDH, forward: 5'-CATCAAGAAGGTGGTGAAGC-3' and reverse: 5'-CATCGAAGGTGGAAGAGTTGG-3' in the same PCR reaction. Quantification was performed through calculation of RQ ). Ct (threshold cycle) for a primer minus -Ct for GAPDH =ΔCt and then, this is referred to wt control values (KO ΔCt-wt ΔCt= ΔΔCt) to calculate RQ value.
In addition, an Invitrogen custom RNA profiling by RT-qPCR was performed in order to analyze more genes: pro-fibrotic genes, Acta2 (α-SMA) and Snail; anti-fibrotic genes (Bmp7, Hgf); genes from TGF-β superfamily (Smad2, Smad3, Smad4, Smad6, Smad7,Tgfβ1, Tgfβ2, Tgfβ3, Tgfβr1/ALK5, Tgfβr2) and different genes involved in the regulation of ROS metabolism (Nox1, Nox4, Noxa1, Noxo1, Gpx1, Gpx2, Gpx3, Cat, Sod1, Sod2, Sod3). However, we just found significant differences in the expression of Tgfβ2, Tgfβ3 and Acta2 mRNAs, but not in the rest of the genes.
Western-blot analysis
Western-blot analysis was carried out as previously described (Zuluaga et al., 2007) using total cell extracts. Proteins were separated by electrophoresis using Anderson gels (or SDS-page gels) and transferred to nitrocellulose membranes that were probed with the following antibodies: catalase (Sigma, C-0979), SOD-2 (Upstate Biotech, 06-984), β-actin (Sigma A5441), c-Met (Sta. Cruz Biotechnology sc-260), cytochrome c (BD 556433); porin (Sigma V2139).
Histology
Embryos and adult hearts were processed for histology using conventional techniques of paraformaldehyde fixation and paraffin embedding. Haematoxylin-eosin and Mallory's trichrome staining were performed on deparaffinated sections. Laminin immunohistochemistry was used to delineate the cardiomyocyte profiles. Briefly, deparaffinated 10 µm sections were rehydrated, blocked with 16% sheep serum in Tris-PBS, and incubated o/n at 4ºC with a rabbit polyclonal anti-laminin antibody (Sigma L9393). After washing, sections were incubated with a fluorochrome conjugated anti-rabbit IgG antibody, washed, and observed in a Leica confocal microscope. Image analysis was performed on confocal images from the laminin immunostaining, in areas where the cardiomyocytes were transversely sectioned. Cardiomyocyte profiles were hand-drawn on a transparent mask placed on the images using Photoshop software. The inversion of these images provided spots corresponding to the cardiomyocyte sections. The area of these spots was measured using the image analysis package Image J.
Detection of activated caspase-3, a marker of apoptosis, was performed through immunohistochemistry using a rabbit polyclonal antibody from Promega (G74819. For double staining, of apoptotic cardiomyocytes and anti-desmin antibody (Sigma) was used. The degree of interstitial fibrosis was assessed by image analysis on trichrome stained tissue sections. Collagen is stained in blue and myocardiocytes in red. Digital images were obtained from three specimens by group (mutant/wildtype, males/females). RGB channels were split, and the red channel (where blue color appears as dark grey) was analyzed using the ImageJ package. A uniform threshold level was applied to all the figures, and the originally blue (i.e. fibrotic) areas appeared as black surfaces. The percentage of the black surface relative to the total surface was determined and mean value and standard deviation was obtained for each group.
ROS detection and quantification
ROS accumulation in the heart was detected upon staining of frozen sections with 1µM 2-hydroethidine (in PBS) for 20 min at 37ºC in the dark. The sections were then washed with PBS, mounted and analyzed by fluorescence microscopy. The number of stained nuclei was counted on digitalized images using ImageJ software. In addition, carbonylated proteins were quantified as an indirect measurement of ROS (Richert et al., 2002) . Basically, heart extracts were treated with 10 mM 2,4-Dinitrophenylhydrazine (DNPH) in 2M HCl (Sigma D-2630) for 1h at room temperature in the dark. As a control, half of the sample was not treated with DNPH (blank). Then, proteins were precipitated with 10% TCA. Pellets were washed 3 times with ethanol: ethyl-acetate, resuspended in 6M guanidine at pH 2.5 and the absorbance at 360 nm was determined. The concentration of carbonylated proteins for each sample was calculated upon correction with the blanks (extinction coefficient=22000 nmol/l/cm) and was referred to protein content.
In 9 months old mice, oxidative stress was assessed on paraffin sections by immunohistochemistry using an anti 4-hydroxynonenal antibody (HNE11-S, Alpha Diagnostic International). Stained areas of the tissue were also assessed by image analysis.
Measurement of catalase and SOD activities
Catalase activity was measured by quantification of peroxide decomposition in a 50 mM phosphate buffer at pH 7 containing 3mM H 2 O 2 . This was monitored spectrophotometrically at 240 nm. SOD activity from cell extracts was quantified using a Kit (BioVision, ref. #K335-100), where WST-1 (2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfo-phenyl)-2H tetrazolium, monosodium salt) is the substrate. WST-1 produces a water-soluble formazan dye upon its reduction with superoxide anion, which can be monitored spectrophotometrically at 450nm. This rate of reduction is linearly related to the xanthine oxidase activity and inhibited by SOD, so the IC50 of SOD is determined as a measure of SOD activity.
Electrocardiographic measurements in conscious mice using radiotelemetry Electrocardiograms (ECGs) were performed in conscious mice using a radiotelemetry system (Data Science International, St Paul, MN, USA). Mice were anaesthetized and a radiotelemetry transmitter (PhysioTel ® model EA-F20, Data Science International) was implanted in the scruff of the neck, with the negative lead sutured in the muscle just under the right clavicle and the positive lead placed left of the xiphoid process. The mice were housed in individual cages for at least 5 days post-implantation before ECG recordings were obtained. Recordings were taken every 3 h, for a duration of 5 min/each, over a 24 h period, during which the mice had access to food and water ad libitum and were exposed to a 12 h light-dark cycle. Analysis of the recording was performed using ECG-auto software supplied by Data Systems.
Ecocardiographic assessment of cardiac function and structure Transthoracic echocardiography was performed using an Vivid 7 (GE Medical Systems) cardiac ultrasound machine equipped with a 10-14-MHz transducer il3L (GE Medical Systems) by a single experienced operator who was blinded to the mice genotype, as previously described (Grande et al. 2011) . In brief, mice were lightly sedated by intraperitoneal administration of a combination of ketamine, atropine and midazolam and maintained on a heated platform. Heart rates are generally maintained at more than 500 per minute with these regimens. Each mouse was gently held in the palm of the hand by securing the skin of the dorsal neck with the thumb and the index finger, and securing the tail between the handler's last two fingers. While in the supine position the hair chest was removed and prewarmed hypoallergenic gel was applied in order to improve the ultrasonic penetration and the quality of images. Animal handling care was taken to minimize excessive pressure of the transducer on the chest wall and to avoid reflex bradycardia.
Two dimensional images were recorded in long and short axis projection with guided Mmode recordings at the level of the papillary muscle. Generally the sweep speed was of 200 mm/s and image depth of 10 mm. Left ventricular (LV) cavity size and wall thickness were measured using the leading-edge technique adopted by the American Society of Echocardiography, in at least three beats (3) (4) (5) from each projection and averaged.
LV wall thickness {interventricular septum (IVS) and posterior wall (PW) thickness} and internal dimensions at diastole and systole (LVEDD and LVESD), respectively, were measured. LV fractional shortening was calculated as {(LVEDD-LVESD)/LVEDD}x100, LV ejection fraction as (LVEDV-LVESV/LVEDV*100), LV mass as {1.05x{(PW+AW+LVEDD) 3 -(LVEDD) 3 }, and relative wall thickness (RWT) as {(2xPW)/LVEDD}. End-diastolic and endsystolic volumes, LVEDV and LVESV respectively {7/(2.4+LVEDV) x LVEDV 3 }, stroke volume (LVEDV-LVESV) and cardiac output (heart rate x stroke volume) were also determined.
Measurements of chamber dimensions and cardiac function were made offline (EchoPac Software, GE Medical Systems) and all echocardiographic parameters were averaged from at least three cardiac cycles.
